Recommendations for the coordinated management of psoriatic arthritis by rheumatologists and dermatologists: A Delphi study;Elaboración mediante el método Delphi de recomendaciones para el manejo coordinado (reumatólogo/dermatólogo) de la artritis psoriásica

Actas Dermo-Sifiliograficas

Volumn 105, Issue 3, 2014, Pages 216-232

  Canete J D ^a   Dauden E ^b   Queiro, R ^c   Aguilar, M D ^d   Sanchez Carazo J L ^e   Carrascosa, J M ^f   Carretero, G ^g   Garcia Vivar M L ^h   Lazaro P ^d   Lopez Estebaranz J L ⁱ   Montilla, C ^j   Ramirez J ^a   Rodriguez Moreno J ^k   Puig, L ^l  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d Tecnicas Avanzadas de Investigacion en Servicios de Salud TAISS   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^g HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^h HOSPITAL DE BASURTO   (Spain)

ⁱ HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^j HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^k HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^l HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

more..

Author keywords

Clinical recommendations; Coordinated management; Psoriatic arthritis

Indexed keywords

ALGORITHM; ARTICLE; DELPHI STUDY; DERMATOLOGIST; HUMAN; PATIENT REFERRAL; PRACTICE GUIDELINE; PSORIATIC ARTHRITIS; RHEUMATOLOGY; TREATMENT OUTCOME; ARTHRITIS, PSORIATIC; DERMATOLOGY; PATIENT CARE;

ALGORITHMS; ARTHRITIS, PSORIATIC; DELPHI TECHNIQUE; DERMATOLOGY; HUMANS; PATIENT CARE TEAM; RHEUMATOLOGY;

EID: 84898002523     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.adengl.2013.07.003     Document Type: Short Survey

References (58)

1. R.S. Stern, T. Nijsten, S.R. Feldman, D.J. Margolis, and T. Rolstad Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction J Investig Dermatol Symp Proc 9 2004 136 139
2. D.D. Gladman, C. Antoni, P. Mease, D.O. Clegg, and P. Nash Psoriatic arthritis: Epidemiology, clinical features, course, and outcome Ann Rheum Dis 64 Suppl 2 2005 ii14 ii17
3. A.P. Anandarajah, and C.T. Ritchlin The diagnosis and treatment of early psoriatic arthritis Nat Rev Rheumatol 5 2009 634 641
4. E. Christophers, J.N.W.N. Barker, C.E.M. Griffiths, E. Daudén, G. Milligan, and C. Molta et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics J Eur Acad Dermatol Venereol 24 2010 548 554
5. A. García-Díez, C. Ferrándiz-Foraster, F. Vanalocha-Sebastián, L. Lizán-Tudela, X. Badía-Llach, and G. Sellers-Fernández What characterizes the severity of psoriasis? Results from an epidemiological study of over 3,300 patients in the Iberian region Dermatology 216 2008 137 151
6. K.B. Sokoll, and P.S. Helliwell Comparison of disability and quality of life in rheumatoid and psoriatic arthritis J Rheumatol 28 2001 1842 1846
7. A.F. Kavanaugh, and C.T. Ritchlin Systematic review of treatments for psoriatic arthritis: An evidence based approach and basis for treatment guidelines J Rheumatol 33 2006 1417 1421
8. I.N. Bruce Psoriatic arthritis: clinical features M.C. Hochberg, A.J. Silman, J.S. Smolen, M.E. Weinblatt, M.H. Weisman, Rheumatology 2008 Mosby-Elsevier Philadelphia 1165 1175
9. J. Moll, and V. Wright Psoriatic arthritis Semin Arthritis Rheum 3 1973 55 78
10. W. Taylor, D. Gladman, P. Helliwell, A. Marchesoni, P. Mease, and H. Mielants Classification criteria for psoriatic arthritis: Development of new criteria from a large international study Arthritis Rheum 54 2006 2665 2673
11. J.C. Torre Alonso Utilidad y aplicación en la práctica clínica de los criterios CASPAR Reumatol Clin 6 Suppl 1 2010 18 21
12. M. Haroon, B. Kirby, and O. FitzGerald High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires Ann Rheum Dis 72 2013 736 740
13. D.D. Gladman, A. Thavaneswaran, V. Chandran, and R.J. Cook Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease Ann Rheum Dis 70 2011 2152 2154
14. Z.R. Ash, I. Tinazzi, C.C. Gallego, C. Kwok, C. Wilson, and M. Goodfield et al. Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails Ann Rheum Dis 71 2012 553 556
15. W. Li, J. Han, and A.A. Qureshi Obesity and risk of incident psoriatic arthritis in US women Ann Rheum Dis 71 2012 1267 1272
16. T.J. Love, Y. Zhu, Y. Zhang, L. Wall-Burns, A. Ogdie, and J.M. Gelfand et al. Obesity and the risk of psoriatic arthritis: A population-based study Ann Rheum Dis 71 2012 1273 1277
17. J.D. Cañete, and P. Mease The link between obesity and psoriatic arthritis Ann Rheum Dis 71 2012 1265 1266
18. M.E. Husni, K.H. Meyer, D.S. Cohen, E. Mody, and A.A. Qureshi The PASE questionnaire: Pilot-testing a psoriatic arthritis screening and evaluation tool J Am Acad Dermatol 57 2007 581 587
19. G.H. Ibrahim, M.H. Buch, C. Lawson, R. Waxman, and P.S. Helliwell Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: The Psoriasis Epidemiology Screening Tool (PEST) questionnaire Clin Exp Rheum 27 2009 469 474
20. D.D. Gladman, C.T. Schentag, B.D. Tom, V. Chandran, J. Brockbank, and C. Rosen et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: The Toronto Psoriatic Arthritis Screen (TOPAS) Ann Rheum Dis 68 2009 497 501
21. P.M. Peloso, M. Behl, P. Hull, and B. Reeder The Psoriasis Arthritis Questionnaire (PAQ) in detection of arthritis among patients with psoriasis Arthritis Rheum 40 Suppl 9 1997 S64
22. I. Tinazzi, S. Adami, E.M. Zanolin, C. Caimmi, S. Confente, and G. Girolomoni et al. The early psoriatic arthritis screening questionnaire: A simple and fast method for the identification of arthritis in patients with psoriasis Rheumatology 51 2012 2058 2063
23. E. Dauden, S. Castañeda, C. Suárez, J. García- Campayo, A.J. Blasco, and M.D. Aguilar et al. Grupo de Trabajo en Comorbilidades Asociadas a la Psoriasis. Abordaje integral de la comorbilidad del paciente con psoriasis Actas Dermosifiliogr 103 Suppl 1 2012 1 64
24. E. Daudén, S. Castañeda, C. Suárez, J. García-Campayo, A.J. Blasco, and M.D. Aguilar et al. Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis J Eur Acad Dermatol Venereol 2012 10.1111/jdv.12024
25. A. Menter, A. Gottlieb, S.R. Feldman, A.S. van Voorhees, C.L. Leonardi, and K.B. Gordon et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics J Am Acad Dermatol 58 2008 826 850
26. A. Gottlieb, N.J. Korman, K.B. Gordon, S.R. Feldman, M. Lebwohl, and J.Y.M. Koo et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 2. Psoriatic arthritis: Overview and guidelines of care for treatment with an emphasis on the biologics J Am Acad Dermatol 58 2008 851 864
27. C.T. Ritchlin, A. Kavanaugh, D.D. Gladman, P.J. Mease, P. Helliwell, and W-H. Boehncke et al. Treatment recommendations for psoriatic arthritis Ann Rheum Dis 68 2009 1387 1394
28. Sociedad Española de Reumatología (SER). ESPOGUIA. Guía de Práctica Clínica sobre el manejo de los pacientes con Espondiloartritis. Madrid: SER; 2009. [consultado 22 Ago 2013]. Disponible en: http://www.ser.es/practicaClinica/Guias-practica-clinica/Guias-finalizadas. php.
29. J.L. Fernández-Sueiro, X. Juanola-Roura, J.D. Cañete- Crespillo, J.C. Torre-Alonso, R. García de Vicuña, and R. Queiro-Silva et al. Documento SER de consenso sobre el uso de terapias biológicas en la artritis psoriásica Reumatol Clin 7 2011 179 188
30. P. Machado, M. Bogas, A. Ribeiro, J. Costa, A. Neto, and A. Sepriano et al. 2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis Acta Reumatol Port 37 2012 26 39
31. L. Gossec, J.S. Smolen, C. Gaujoux-Viala, Z. Ash, H. Mar-Ortega, and D. van der Heijde et al. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies Ann Rheum Dis 71 2012 4 12
32. National Clinical Guideline Centre (NCGC) Psoriasis: Assessment and Management of Psoriasis. Clinical Guideline: Methods, Evidence and Recommendations 2012 NCGC London
33. Centre for Evidence Based Medicine (CEBM) [Internet]. Oxford Centre for Evidence-based Medicine - Levels of Evidence (March 2009). Oxford: CEBM; 2012. [consultado 22 Ago 2013]. Disponible en: http://www.cebm.net/index.aspx?o=1025
34. I. Tinazzi, D. Mcgonagle, D. Biasi, S. Confente, C. Caimmi, and G. Girolomoni et al. Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis J Rheumatol 38 2011 12
35. J.E. Brockbank, M. Stein, C.T. Schentag, and D.D. Gladman Dactylitis in psoriatic arthritis: A marker for disease severity Ann Rheum Dis 64 2005 188 190
36. J.S. Smolen, J. Braun, M. Dougados, P. Emery, O. Fitzgerald, and P. Helliwell et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: Recommendations of an international task force Ann Rheum Dis 2013 [Epub ahead of print]
37. L. Puig, X. Bordas, J.M. Carrascosa, E. Daudén, C. Ferrándiz, and J.M. Hernanz et al. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology Actas Dermosifiliogr 100 2009 277 286
38. D.D. Gladman Adalimumab etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis Nat Clin Pract Rheumatol 4 2008 510 511
39. A. Migliore, E. Bizzi, S. Broccoli, and B. Laganà Indirect comparison of etanercept, infliximab, and adalumimab for psoriatic arthritis: Mixed treatment comparison using placebo as common comparator Clin Rheumatol 31 2012 193 194
40. A.A. Saad, D.M. Ashcroft, K.D. Watson, K.L. Hyrich, P.R. Noyce, and D.P. Symmons Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: Observational study from the British Society of Rheumatology Biologics Register. British Society for Rheumatology Biologics Register Arthritis Res Ther 11 2009 R52
41. L. Carmona, and J.J. Gómez-Reino Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Spanish registry BIOBADASER Arthritis Res Ther 8 2006 R72
42. M. Esposito, A. Giunta, A. Mazzotta, A. Zangrilli, G. Babino, and M. Bavetta et al. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: An observational long-term study Dermatology 225 2012 312 319
43. F. Cantini, L. Niccoli, E. Cassarà, O. Kaloudi, and C. Nannini Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: A long-term follow-up study Biologics 6 2012 201 206
44. P.J. Mease Assessment tools in psoriatic arthritis J Rheumatol 35 2008 1426 1430
45. P.J. Mease, C.E. Antoni, D.D. Gladman, and W.J. Taylor Psoriatic arthritis assessment tools in clinical trials Ann Rheum Dis 64 Suppl 2 2005 ii49 ii54
46. C. Salliot, E. Dernis, F. Lavie, A. Cantagrel, P. Gaudin, and D. Wendling et al. Diagnosis of peripheral psoriatic arthritis: Recommendations for clinical practice based on data from the literature and experts opinion Joint Bone Spine 76 2009 532 539
47. J. Santos-Juanes, and C. Galache Reacciones cutáneas psoriasiformes durante el tratamiento con etanercept Actas Dermosifiliogr 101 Supl 1 2010 106 110
48. A.N. Collamer, K.T. Guerrero, J.S. Henning, and D.F. Battafarano Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action Arthritis Rheum 59 2008 996 1001
49. A. López-Ferrer, V. Torrente-Segarra, and L. Puig Artritis psoriásica: lo que el dermatólogo debe saber (parte 1) Actas Dermosifiliogr 101 2010 578 584
50. A. López-Ferrer, V. Torrente-Segarra, and L. Puig Artritis psoriásica: lo que el dermatólogo debe saber (parte 2) Actas Dermosifiliogr 101 2010 742 748
51. J.L. López-Estebaranz, P. Zarco-Montejo, J. Escalas-Tabernert, M. García-Rodríguez, J.F. García-Llorente, and C. García-Calvo Manejo de la artritis psoriásica en España: estudio Calipso Actas Dermosifiliogr 101 2010 629 636
52. M. Gutierrez, E. Filippucci, R. de Angelis, F. Salaffi, G. Filosa, and S. Ruta et al. Subclinical entheseal involvement in patients with psoriasis: An ultrasound study Semin Arthritis Rheum 40 2011 407 412
53. C. De Simone, G. Caldarola, M. d'Agostino, A. Carbone, C. Guerriero, and L. Bonomo et al. Usefulness of ultrasound imaging in detecting psoriatic arthritis of fingers and toes in patients with psoriasis Clin Dev Immunol 2011 2011 390726
54. D. McGonagle, W. Gibbon, P. O'Connor, M. Green, C. Pease, and P. Emery Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy Arthritis Rheum 41 1998 694 700
55. Y. Emad, Y. Ragab, T. Gheita, A. Anbar, H. Kamal, and A. Saad et al. Knee enthesitis and synovitis on magnetic resonance imaging in patients with psoriasis without arthritic symptoms J Rheumatol 39 2012 1979 1986
56. N. Raza, A. Hameed, and M.K. Ali Detection of subclinical joint involvement in psoriasis with bone scintigraphy and its response to oral methotrexate Clin Exp Dermatol 33 2008 70 73
57. T. Takata, Y. Taniguchi, T. Ohnishi, S. Kohsaki, M. Nogami, and H. Nakajima et al. (18)FDG PET/CT is a powerful tool for detecting subclinical arthritis in patients with psoriatic arthritis and/or psoriasis vulgaris J Dermatol Sci 64 2011 144 147
58. L.C. Coates, J. Fransen, and P.S. Helliwell Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment Ann Rheum Dis 69 2010 48 53